FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Edwards Lifesciences: Tavr Sales Expansion Drives Q1 Eps Beat

By

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Edwards Lifesciences reported strong Q1 results with sales growing 16.7% Y/Y to $1.65B and adjusted EPS of $0.78, beating consensus estimates by $0.05. Operating margin expanded to 31.4% from 29.1% in the prior-year quarter, supported by $500M in quarterly share repurchases. The company benefits from momentum generated by EARLY TAVR study data driving earlier disease intervention, while Boston Scientific's European market exit strengthened EW's TAVR positioning, in our view. EW raised full-year 2026 guidance to 10% constant currency sales growth and $3.00 adjusted EPS midpoint, representing 17% growth vs. 2025. TAVR sales of $1.20B grew 14.4% Y/Y supported by SAPIEN growth globally, with raised guidance to 8% midpoint from 7% previously. TMTT sales surged 51.9% Y/Y driven by PASCAL adoption and higher EVOQUE utilization as procedure volumes rose in the double digits. We expect continued operating margin expansion toward the high end of EW's 28%-29% guidance range in 2026.

Related Articles

Research

Research Alert: Rollins Prints Mixed Q1 As Margins Fail To Impress

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ROL's Q1 results were mixed, achieving revenue growth of 10.2% Y/Y split between 6.6% organic growth and 3.6% from acquisitions. However, margin compression remained a headwind, with adjusted operating margin declining 100 bps to 16.9%. ROL faced challenges balancing growth investments while defending profitability, with the termite business remaining the standout performer at 13.5% revenue growth and 9.8% organic expansion, outpacing residential services which rose 9.3% overall but just 4.2% organically. Management attributed margin pressures to insurance/claims costs, people costs, and selling investments, with employee expenses rising to 32.0% of revenue from 31.8% and insurance costs increasing to 2.3% from 2.0%. Cash flows weakened significantly, with operating cash flow declining 19.4% and free cash flow down 20.6%, impacted by timing factors, a $40M tax credit strategy, and $9M from interest payment transitions. We see previous share price highs being elusive until margins show signs of stabilization.

$ROL
Research

Research Alert: United Rentals Prints Q1 Beat As Margins Bounce Back

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:URI delivered strong Q1 results with operating EPS of $9.71, beating consensus by $0.77, while total revenue reached $3.9B (+7.2%) with rental revenue of $3.4B (+8.7%). Adjusted EBITDA margin of 44.1% declined 80 bps Y/Y, but excluding the prior year H&E merger termination benefit, margins actually expanded 60 bps, signaling an important inflection from persistent compression. We see this as evidence that management's restructuring efforts are paying off, with margin pressures finally showing signs of stabilization. The strong quarter enabled URI to raise full-year revenue guidance to $16.9B-$17.4B and adjusted EBITDA to $7.625B-$7.875B. Segment results were mixed, with general rentals achieving 6.2% revenue growth and 150 bps margin expansion to 33.8%, while specialty rentals posted robust 13.8% revenue growth but faced 170 bps margin compression to 41.4%. We believe leverage remains well below historical levels, positioning URI for accretive M&A deals that could generate additional guidance lifts.

$URI
Research

Research Alert: Fico Loses Its Grip - Fhfa Opens Door To Rivals

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FICO's stranglehold on mortgage credit scoring officially ended as FHFA Director Bill Pulte announced that "effective immediately," Fannie Mae and Freddie Mac would accept VantageScore, FICO's main competitor, credit models. HUD Secretary Scott Turner said FHA would follow within months. FICO shares plunged 10%+ on the news. Until now, GSEs relied almost exclusively on older FICO models, giving FICO monopolistic control over mortgage financing access. This dominance recently prompted Senator Josh Hawley to investigate FICO's pricing practices. VantageScore costs $0.99 versus FICO's $4.95-$10 plus fees, and uses alternative data like rent payments to score borrowers. We believe this announcement will heavily expand mortgage access, with millions previously excluded by traditional scoring and high costs. This announcement poses a massive headwind for FICO, breaking its monopoly and introducing intense pricing competition unseen in decades. We're watching FICO's April 28 earnings call for management's response.

$FICO